Related Experiment Video
Updated: May 24, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Biomarkers for systemic lupus erythematosus.
Joseph M Ahearn1, Chau-Ching Liu, Amy H Kao
1Lupus Center of Excellence, Department of Medicine, Allegheny Singer Research Institute, West Penn Allegheny Health System and Temple University School of Medicine, 320 E. North Avenue, Pittsburgh, PA 15212, USA. jahearn@wpahs.org.
Summary
Identifying reliable biomarkers for systemic lupus erythematosus (SLE) is crucial. Current research aims to find validated biomarkers for SLE diagnosis, monitoring, and predicting disease flares, which are currently lacking.
Area of Science:
- Immunology
- Rheumatology
- Biomarker Discovery
Background:
- Systemic lupus erythematosus (SLE) lacks validated biomarkers for clinical decision-making.
- The absence of reliable biomarkers hinders patient management and therapeutic development.
- A 2011 FDA workshop highlighted the urgent need for lupus biomarkers, particularly for predicting disease flares.
Purpose of the Study:
- To address the critical need for validated biomarkers in SLE.
- To accelerate the identification and validation of biomarkers for SLE diagnosis, monitoring, stratification, and flare prediction.
Main Methods:
- Review of existing research and expert discussions from the 2011 FDA workshop.
- Ongoing investigation into potential biomarker candidates for SLE.
- Focus on developing biomarkers for disease flare prediction.
Main Results:
- No definitive biomarkers for predicting lupus flares have been identified to date.
- Few biomarkers for SLE diagnosis, monitoring, and stratification are validated for clinical use.
- Intensified research efforts are underway to discover and validate SLE biomarkers.
Conclusions:
- There is a significant unmet need for validated biomarkers in SLE management.
- Continued investigation offers cautious optimism for the future development of a comprehensive biomarker panel for SLE.
- Validated biomarkers are essential for improving patient care and advancing SLE therapeutics.
